These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


822 related items for PubMed ID: 25637338

  • 1. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
    Agudelo CA, Muñoz C, Ramírez A, Tobón AM, de Bedout Bact C, Cano LE, Restrepo A.
    Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
    [Abstract] [Full Text] [Related]

  • 2. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W, Sungkanuparph S, Thongyen S, Chumpathat N, Eampokalap B, Thawornwan U, Foongladda S.
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [Abstract] [Full Text] [Related]

  • 3. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species.
    Bongomin F, Oladele RO, Gago S, Moore CB, Richardson MD.
    Mycoses; 2018 May; 61(5):290-297. PubMed ID: 29377368
    [Abstract] [Full Text] [Related]

  • 4. Current approach to the acute management of cryptococcal infections.
    Powderly WG.
    J Infect; 2000 Jul; 41(1):18-22. PubMed ID: 11041709
    [No Abstract] [Full Text] [Related]

  • 5. Timed-kill curves for Cryptococcus neoformans isolated from patients with AIDS.
    Rodero L, Córdoba S, Cahn P, Soria M, Lucarini M, Davel G, Kaufman S, Canteros C, Guelfand L.
    Med Mycol; 2000 Jun; 38(3):201-7. PubMed ID: 10892987
    [Abstract] [Full Text] [Related]

  • 6. Fluconazole Non-susceptible Cryptococcus neoformans, Relapsing/Refractory Cryptococcosis and Long-term Use of Liposomal Amphotericin B in an AIDS Patient.
    de Carvalho Santana R, Schiave LA, Dos Santos Quaglio AS, de Gaitani CM, Martinez R.
    Mycopathologia; 2017 Oct; 182(9-10):855-861. PubMed ID: 28656554
    [Abstract] [Full Text] [Related]

  • 7. Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy.
    Arechavala AI, Ochiuzzi ME, Borgnia MD, Santiso GM.
    Rev Iberoam Micol; 2009 Sep 30; 26(3):194-7. PubMed ID: 19635445
    [Abstract] [Full Text] [Related]

  • 8. [Disseminated cryptococcosis in patients with AIDS. Clinical, microbiological, and immunological analysis of 51 patients].
    Metta HA, Corti ME, Negroni R, Helou S, Arechavala A, Soto I, Villafañe MF, Muzzio E, Castello T, Esquivel P, Trione N.
    Rev Argent Microbiol; 2002 Sep 30; 34(3):117-23. PubMed ID: 12415893
    [Abstract] [Full Text] [Related]

  • 9. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.
    Pfaller M, Zhang J, Messer S, Tumberland M, Mbidde E, Jessup C, Ghannoum M.
    Diagn Microbiol Infect Dis; 1998 Nov 30; 32(3):191-9. PubMed ID: 9884835
    [Abstract] [Full Text] [Related]

  • 10. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
    Vechi HT, Theodoro RC, de Oliveira AL, Gomes RMODS, Soares RDA, Freire MG, Bay MB.
    BMC Infect Dis; 2019 Mar 04; 19(1):220. PubMed ID: 30832607
    [Abstract] [Full Text] [Related]

  • 11. Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.
    Dannaoui E, Abdul M, Arpin M, Michel-Nguyen A, Piens MA, Favel A, Lortholary O, Dromer F, French Cryptococcosis Study Group.
    Antimicrob Agents Chemother; 2006 Jul 04; 50(7):2464-70. PubMed ID: 16801427
    [Abstract] [Full Text] [Related]

  • 12. Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates.
    Bosco-Borgeat ME, Mazza M, Taverna CG, Córdoba S, Murisengo OA, Vivot W, Davel G.
    Rev Argent Microbiol; 2016 Jul 04; 48(2):137-42. PubMed ID: 27311753
    [Abstract] [Full Text] [Related]

  • 13. Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole.
    Kammalac Ngouana T, Dongtsa J, Kouanfack C, Tonfack C, Fomena S, Mallié M, Delaporte E, Boyom FF, Bertout S.
    J Mycol Med; 2015 Mar 04; 25(1):11-6. PubMed ID: 25467817
    [Abstract] [Full Text] [Related]

  • 14. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002.
    Sar B, Monchy D, Vann M, Keo C, Sarthou JL, Buisson Y.
    J Antimicrob Chemother; 2004 Aug 04; 54(2):563-5. PubMed ID: 15254027
    [Abstract] [Full Text] [Related]

  • 15. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    Friese G, Discher T, Füssle R, Schmalreck A, Lohmeyer J.
    AIDS; 2001 Nov 23; 15(17):2344-5. PubMed ID: 11698718
    [No Abstract] [Full Text] [Related]

  • 16. Emergence of amphotericin B-resistant Cryptococcus laurentii meningoencephalitis shortly after treatment for Cryptococcus neoformans meningitis in a patient with AIDS.
    Manfredi R, Fulgaro C, Sabbatani S, Legnani G, Fasulo G.
    AIDS Patient Care STDS; 2006 Apr 23; 20(4):227-32. PubMed ID: 16623620
    [Abstract] [Full Text] [Related]

  • 17. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
    Trpković A, Pekmezović M, Barać A, Crnčević Radović L, Arsić Arsenijević V.
    J Mycol Med; 2012 Sep 23; 22(3):243-8. PubMed ID: 23518082
    [Abstract] [Full Text] [Related]

  • 18. Fluconazole-resistant cryptococcal meningitis.
    Momoff N, Parrish A.
    S Afr Med J; 2003 Jun 23; 93(6):444. PubMed ID: 12916384
    [No Abstract] [Full Text] [Related]

  • 19. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
    Chang WN, Huang CR, Lei CB, Lee PY, Chien CC, Chang HW, Chang CS, Lu CH.
    Jpn J Infect Dis; 2004 Jun 23; 57(3):113-5. PubMed ID: 15218221
    [Abstract] [Full Text] [Related]

  • 20. [Clinical problems in medical mycology: problem number 41].
    Negroni R, Arechavala A, Maiolo E, Bianchi M, Santiso G, Lehmann E.
    Rev Iberoam Micol; 2011 Jun 23; 28(1):53-5. PubMed ID: 21167296
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 42.